Oppenheimer analyst Shaul Eyal raised his price target for Amdocs to $70 from $65 on valuation. The analyst believes Amdocs is "smoothly and gradually transforming itself" into a software provider positioning itself as "the glue between physical and virtual networks." Additionally, Eyal thinks investors should start paying attention to its growing focus and capabilities within the enterprise arena. Near term, the company's business model continues to offer high predictability and solid cash generation and shareholder return, he adds, while reiterating an Outperform rating on the shares.